ASCENT Trial: Trodelvy Boosts Survival in Triple-Negative Breast Cancer Breast Cancer 4 Mins Read Overview of the ASCENT Trial and Trodelvy The ASCENT Trial (NCT02574455) is a Phase III study that compares Trodelvy (Sacituzumab…
